Clinical Trial

Exhaled Breath Condensate Biomarkers in CARAS

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 28, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a more simple, direct and objective way. To screen the biomarkers that can be identified by CARAS Chinese medicine symptoms and different stages, and to provide a reference basis for individualised diagnosis and treatment of the disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-23.
Trial Details
NCT Number NCT06573450
Lead Sponsor Henan University of Traditional Chinese Medicine
Conditions Combined Allergic Rhinitis and Asthma Syndrome
Enrollment 270 participants
Start Date 2023-04-01
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-28